Is SVBRF or MRK a better dividend investment in 2026?

SVBRF currently yields 666666.67% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: SVBRF offers higher current income.

What is the dividend yield difference between SVBRF and MRK?

SVBRF has a forward dividend yield of 666666.67% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 666663.91 percentage points.

Home › Compare › SVBRF vs MRK

SVBRF vs MRK: Dividend Comparison 2026

SVBRF yields 666666.67% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SVBRF wins by $8.275235618773884e+34M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SVBRF

● Live price

666666.67%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8.275235618773884e+34M

Annual income

$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00

Full SVBRF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — SVBRF vs MRK

📍 SVBRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SVBRF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SVBRF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SVBRF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SVBRF

Annual income on $10K today (after 15% tax)

$56,666,666.67/yr

After 10yr DRIP, annual income (after tax)

$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, SVBRF beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SVBRF + MRK for your $10,000?

SVBRF: 50%MRK: 50%

100% MRK50/50100% SVBRF

Portfolio after 10yr

$4.137617809386942e+34M

Annual income

$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.97%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SVBRF

No analyst data

Altman Z

-8.6

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SVBRF buys

MRK buys

No recent congressional trades found for SVBRF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSVBRFMRK

Forward yield	666666.67% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$8.275235618773884e+34M	$56.8K ✓
Annual income after 10y	$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00 ✓	$9,798.13
Total dividends collected	$8.275075881065991e+34M	$28.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: SVBRF vs MRK ($10,000, DRIP)

Year	SVBRF Portfolio	SVBRF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$66,677,367	$66,666,666.67	$11,206	$366.19	+$66.67M → SVBRF
2	$415,506,651,117	$415,435,306,334.37	$12,650	$502.35	+$415506.64M → SVBRF
3	$2,419,908,598,386,268	$2,419,464,006,269,573.00	$14,407	$694.19	+$2419908598.37M → SVBRF
4	$13,171,697,643,084,456,000	$13,169,108,340,884,183,000.00	$16,585	$967.82	+$13171697643084.44M → SVBRF
5	$67,004,927,492,790,120,000,000	$66,990,833,776,312,020,000,000.00	$19,342	$1,363.89	+$67004927492790120.00M → SVBRF
6	$318,562,277,003,514,840,000,000,000	$318,490,581,731,097,560,000,000,000.00	$22,913	$1,947.19	+$318562277003514871808.00M → SVBRF
7	$1,415,484,168,853,553,000,000,000,000,000	$1,415,143,307,217,159,200,000,000,000,000.00	$27,662	$2,823.89	+$1.415484168853553e+24M → SVBRF
8	$5,878,130,573,362,507,000,000,000,000,000,000	$5,876,616,005,301,833,000,000,000,000,000,000.00	$34,159	$4,173.35	+$5.878130573362507e+27M → SVBRF
9	$22,813,793,009,840,743,000,000,000,000,000,000,000	$22,807,503,410,127,248,000,000,000,000,000,000,000.00	$43,337	$6,308.80	+$2.2813793009840744e+31M → SVBRF
10	$82,752,356,187,738,840,000,000,000,000,000,000,000,000	$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00	$56,776	$9,798.13	+$8.275235618773884e+34M → SVBRF

SVBRF vs MRK: Complete Analysis 2026

SVBRF — Stock

Silver Bear Resources Plc engages in the acquisition, exploration, evaluation, and development of precious metal properties in Russia. The company explores for gold, silver, copper, lead, and zinc deposits. Its principal asset is the Mangazeisky silver project covering a license area of approximately 570 square kilometers located to the north of Yakutsk in the Republic of Sakha. Silver Bear Resources Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.

Full SVBRF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this SVBRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SVBRF vs SCHD SVBRF vs JEPI SVBRF vs O SVBRF vs KO SVBRF vs MAIN SVBRF vs JNJ SVBRF vs ABBV SVBRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.